Comparison between Chemcon Speciality Chemicals IPO and Gland Pharma IPO.
Chemcon Speciality Chemicals IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Gland Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Chemcon Speciality Chemicals IPO is up to ₹318.00 Cr whereas the issue size of the Gland Pharma IPO is up to ₹6,479.55 Cr. The final issue price of Chemcon Speciality Chemicals IPO is ₹340.00 per share and of Gland Pharma IPO is ₹1,500.00 per share.
| Chemcon Speciality Chemicals IPO | Gland Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹1 per share |
| Issue Price (Lower) | ₹338.00 per share | ₹1,490.00 per share |
| Issue Price (Upper) | ₹340.00 per share | ₹1,500.00 per share |
| Issue Price (Final) | ₹340.00 per share | ₹1,500.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 44 shares | 10 shares |
| Fresh Issue Size | 48,52,941 shares | 83,33,333 shares |
| Fresh Issue Size (Amount) | up to ₹165.00 Cr | up to ₹1,250.00 Cr |
| OFS Issue Size | 45,00,000 shares | 3,48,63,635 shares |
| OFS Issue Size (Amount) | up to ₹153.00 Cr | up to ₹5,229.55 Cr |
| Issue Size Total | 93,52,941 shares | 4,31,96,968 shares |
| Issue Size Total (Amount) | up to ₹318.00 Cr | up to ₹6,479.55 Cr |
Chemcon Speciality Chemicals IPO opens on Sep 21, 2020, while Gland Pharma IPO opens on Nov 09, 2020. The closing date of Chemcon Speciality Chemicals IPO and Gland Pharma IPO is Sep 23, 2020, and Nov 11, 2020, respectively.
| Chemcon Speciality Chemicals IPO | Gland Pharma IPO | |
|---|---|---|
| Anchor Bid Date | Sep 18, 2020 | Nov 06, 2020 |
| Issue Open | Sep 21, 2020 | Nov 09, 2020 |
| Issue Close | Sep 23, 2020 | Nov 11, 2020 |
| Basis Of Allotment (Tentative) | Sep 28, 2020 | Nov 17, 2020 |
| Initiation of Refunds (Tentative) | Sep 29, 2020 | Nov 18, 2020 |
| Credit of Share (Tentative) | Sep 30, 2020 | Nov 19, 2020 |
| Listing date (Tentative) | Oct 01, 2020 | Nov 20, 2020 |
| Anchor Lockin End date 1 | Oct 28, 2020 | Dec 17, 2020 |
| Anchor Lockin End date 2 | Dec 27, 2020 | Feb 15, 2021 |
Chemcon Speciality Chemicals IPO P/E ratio is , as compared to Gland Pharma IPO P/E ratio of .
| Chemcon Speciality Chemicals IPO | Gland Pharma IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | 74 | ||||
| Promoter Shareholding (Post-Issue) | 74.47 | 58 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹1245.44 Cr. | ₹24492.42 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Chemcon Speciality Chemicals IPO Retail Individual Investors (RII) are offered 32,73,530 shares while in Gland Pharma IPO retail investors are offered 32,73,530 shares. Qualified Institutional Buyers (QIB) are offered 18,70,589 shares in Chemcon Speciality Chemicals IPO and 86,39,394 shares in Gland Pharma IPO.
| Chemcon Speciality Chemicals IPO | Gland Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 28,05,880 shares | 1,29,59,089 shares |
| Market Maker Reservation | ||
| QIB | 18,70,589 shares | 86,39,394 shares |
| NII | 14,02,942 shares | 64,79,546 shares |
| RII | 32,73,530 shares | 1,51,18,939 shares |
| Employee | ||
| Others | ||
| Total | 93,52,941 shares | 4,31,96,968 shares |
Chemcon Speciality Chemicals IPO subscribed 149.30x in total, whereas Gland Pharma IPO subscribed 2.06x.
| Chemcon Speciality Chemicals IPO | Gland Pharma IPO | |
|---|---|---|
| QIB (times) | 113.54x | 6.40x |
| NII (times) | 449.14x | 0.51x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 41.15x | 0.24x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 149.30x | 2.06x |
